aesPLLA ®

aesPLLA® stimulates the body's collagen production and thus has an ideal effect on the natural volume as well as the elasticity of the skin

aesPLLA® is an innovative and poly-L-lactic acid based product from the manufacturer Oreon Life Science. With the highly effective mesotherapy product, you can safely and visibly beautify the skin of your clients. The solution of the manufacturer Oreon Life Science promotes the formation of collagen in the skin, which makes it gain elasticity and structure. As a result, the skin looks fresher and acquires a youthful glow. This effect is achieved primarily through the contained polylactic acid, which is obtained naturally and consists of various lactic acids that harmonize with each other. At the same time, the product is bio-compatible, which means that it can be completely broken down by the body.

The special mode of action of aesPLLA®

aesPLLA® is a fast-acting, promising and safe product from the manufacturer Oreon Life Science. It increases the elasticity of the skin by effectively stimulating the body's own collagen production. The solution works on the basis of polylactic acids, which can be completely broken down by the body. This mesotherapy product restores volume to the face and, on top of that, smoothes fine lines and light wrinkles. In addition, the product is suitable for improving sagging skin around the cheeks, jawline and eyes.

Polylactic acid is a synthetic biomaterial that can be completely broken down by the body and generally does not cause any immunological reactions. In addition, the effect sets in slowly and lasts on average one to two years without ruining the natural appearance of the skin. The desired inflammatory response boosts collagen formation and usually heals on its own without complications. When you purchase the aesPLLA®, you will soon achieve effective treatment of unwanted signs of aging.

FAQ about the aesPLLA®

For which treatment areas can aesPLLA® be used?
This product is particularly good at treating the following areas: temples, eye bags, cheeks, nasolabial folds, marionette lines, and more extensive areas of the face.

What does the aesPLLA® help against?
This product balances the moisture content of the skin and also increases the body's own collagen formation. As a result, the skin looks firmer, fresher and younger, and visible wrinkles as well as sagging skin and dark spots can also be evened out.

What is contained in a package of the aesPLLA®?
The aesPLLA® consists of an ampoule with a total content of 5 ml.

What ingredients does aesPLLA® consist of?
This product consists mainly of 365 mg of PLLA, which is called poly-L-lactic acid.

How is aesPLLA® prepared for use?
The aesPLLA® should be mixed with 5 ml of sterile, distilled water and 2 ml of lidocaine at least 30 minutes to 2 hours prior to injection. Refer to the associated protocol for detailed preparation and use of this product.

How quickly are the results visible after a treatment with the aesPLLA®?
The achieved effect of the aesPLLA® is usually visible after about 4 to 6 weeks after treatment. However, this can vary individually, depending on the client's skin type, skin structure and treatment preference.

How often should aesPLLA® be applied?
To achieve satisfactory results, it is advisable to use this product mesotherapeutically and in about 2 to 3 sessions. The interval between sessions should be about 6 weeks.

How long do the results last on average after a treatment with aesPLLA®?
The results of this product can last for about 1 to 2 years, depending on the condition of the client's skin. However, this can vary, so the effect may wear off sooner or last longer.

Under what layer of skin may the aesPLLA® be injected?
In general, aesPLLA® should be injected into the subcutaneous dermis using a 21G or 23G needle.

Which cannula should be used to inject the aesPLLA®?
For successful treatment, we recommend the punctured fan technique, which achieves the best possible and therefore satisfactory results.

What dose of the aesPLLA® should be injected at each treatment area?
Depending on the treatment area, the respective injection dose of this product to be used differs. Thus, approximately 2 to 3 ml should be used on each temporal side, 1 to 1.5 ml on each lacrimal sac, and 2 to 2.5 ml on each cheek. Furthermore, it is recommended that a dose of 2 to 2.5 ml be applied to one nasolabial fold at a time, 1 to 1.5 ml to each marionette fold, and approximately 6 ml to rather larger areas of the face.

Dispensing may only be done with an original physician's prescription. This regulation does not apply to any party involved in the medical profession, as well as health care.
The manufacturer and we as the seller point out that an injection with products with and without lidocaine should be performed only by trained and medically trained personnel.